SCHEMBL7401205

SCHEMBL7401205

Fc1cc(OCCBr)ccc1Oc1ccccc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LTA4H P09960 4/20 0.45
PLA2G2A P14555 1/20 0.45
PPARG P37231 3/20 0.44
PPARD Q03181 2/20 0.44
FFAR1 O14842 2/20 0.44
NPC1 O15118 1/20 0.43
MAPT P10636 1/20 0.43
RAB9A P51151 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
PPARA Q07869 2/20 0.40
SCN9A Q15858 1/20 0.39
HTR2A P28223 1/20 0.39
SLC6A4 P31645 1/20 0.39
FFAR4 Q5NUL3 1/20 0.39
ERBB2 P04626 1/20 0.39
TAAR1 Q96RJ0 1/20 0.38
KCNQ3 O43525 1/20 0.38
KCNQ2 O43526 1/20 0.38
KCNE1 P15382 1/20 0.38
KCNQ1 P51787 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10877827 0.84 ALDH1A1 (0.55) LTA4HPLA2G2APPARGPPARDFFAR1
SCHEMBL7371207 0.82 FFAR1 (0.46) PPARGPPARDFFAR1SCN9A
SCHEMBL7401147 0.81 PPARG (0.46) LTA4HPLA2G2APPARGPPARDNPC1
SCHEMBL2291508 0.77 LTA4H (0.64) LTA4HPLA2G2APPARATAAR1
SCHEMBL18492657 0.76 FAAH (0.42) LTA4HPPARGPPARDFFAR1SMN1; SMN2
SCHEMBL30025481 0.76 MAOB (0.45) PPARGPPARDFFAR1NPC1MAPT
SCHEMBL5706897 0.76 MAOB (0.45) PPARGPPARDFFAR1NPC1MAPT
SCHEMBL8405400 0.76 TTR (0.47) LTA4HPPARDHTR2ASLC6A4ERBB2
SCHEMBL23647531 0.75 LTA4H (0.55) LTA4HSMN1; SMN2
SCHEMBL11027702 0.74 HRH1 (0.43) LTA4HPLA2G2AMAPTSLC6A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6124323-A ACTIVE DRUG TREATING STROKE, CEREBRAL ISCHEMIA, CENTRAL NERVOUS SYSTEM TRAUMA, HYPOGLYCEMIA, ANXIETY, CONVULSIONS, AMIOGLYCOSIDE ANTIBIOTICS-INDUCED HEARING LOSS, MIGRAINE HEADACHES, CHRONIC PAIN, GLAUCOMA, CMV RETINITIS, PSYCHOSIS WARNER-LAMBERT COMPANY (US) 2000-09-26 US disclosed
EP-0869792-A4 4-SUBSTITUTED PIPERIDINE ANALOGS AND THEIR USE AS SUBTYPE SELECTIVE NMDA RECEPTOR ANTAGONISTS WARNER LAMBERT CO (US) 1999-09-22 EP disclosed
EP-0869792-A2 4-SUBSTITUTED PIPERIDINE ANALOGS AND THEIR USE AS SUBTYPE SELECTIVE NMDA RECEPTOR ANTAGONISTS WARNER-LAMBERT COMPANY (US) 1998-10-14 EP disclosed
WO-1997023216-A1 4-SUBSTITUTED PIPERIDINE ANALOGS AND THEIR USE AS SUBTYPE SELECTIVE NMDA RECEPTOR ANTAGONISTS WARNER-LAMBERT COMPANY (US) 1997-07-03 WO disclosed